Impulsive action and impulsive choice are mediated by distinct neuropharmacological substrates in rat

International Journal of Neuropsychopharmacology

Volumn 15, Issue 10, 2012, Pages 1473-1487

  Paterson, Neil E ^a   Wetzler, Caitlin ^a   Hackett, Adrian ^a   Hanania, Taleen ^a  

^a PSYCHOGENICS INC   (United States)

Author keywords

5 CSRTT; Atomoxetine; delayed discounting task; methylphenidate; serotonin

Indexed keywords

6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; ATOMOXETINE; KETANSERIN; METHYLPHENIDATE;

ANIMAL EXPERIMENT; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; FOLLOW UP; IMPULSIVENESS; MALE; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING;

ADRENERGIC UPTAKE INHIBITORS; AMINOPYRIDINES; ANIMALS; CHOICE BEHAVIOR; DOPAMINE UPTAKE INHIBITORS; IMPULSIVE BEHAVIOR; INDOLES; KETANSERIN; MALE; METHYLPHENIDATE; PROPYLAMINES; RATS; RATS, LONG-EVANS; REACTION TIME; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS;

EID: 84867243166     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711001635     Document Type: Article

References (40)

1. Bari A, Dalley JW, Robbins TW (2008). The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats. Nature Protocols 3, 759-767.
2. Bari A, Eagle DM, Mar AC, Robinson ES, Robbins TW (2009). Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats. Psychopharmacology 205, 273-283.
3. Bizarro L, Patel S, Murtagh C, Stolerman IP (2004). Differential effects of psychomotor stimulants on attentional performance in rats : nicotine, amphetamine, caffeine and methylphenidate. Behavioral Pharmacology 15, 195-206.
4. Blondeau C, Dellu-Hagedorn F (2007). Dimensional analysis of ADHD subtypes in rats. Biological Psychiatry 61, 1340-1350.
5. Boulougouris V, Glennon JC, Robbins TW (2008). Dissociable effects of selective 5-HT2A and 5-HT2C receptor antagonists on serial spatial reversal learning in rats. Neuropsychopharmacology 33, 2007-2019.
6. Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, et al. (2002). Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat : a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27, 699-711.
7. Chamberlain SR, Del Campo N, Dowson J, Mü ller U, et al. (2007). Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biological Psychiatry 62, 977-984.
8. Day M, Pan JB, Buckley MJ, Cronin E, et al. (2007). Differential effects of ciproxifan and nicotine on impulsivity and attention measures in the 5-choice serial reaction time test. Biochemical Pharmacology 73, 1123-1134.
9. Eagle DM, Baunez C (2010). Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition. Neuroscience and Biobehavioral Reviews 34, 50-72.
10. Fletcher PJ, Rizos Z, Noble K, Higgins GA (2011). Impulsive action induced by amphetamine, cocaine and MK801 is reduced by 5-HT(2C) receptor stimulation and 5-HT(2A) receptor blockade. Neuropharmacology 61, 468-477.
11. Fletcher PJ, Tampakeras M, Sinyard J, Higgins GA (2007). Opposing effects of 5-HT(2A) and 5-HT(2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test. Psychopharmacology 195, 223-234.
12. Han DD, Gu HH (2006). Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacology 6, 6.
13. Higgins GA, Enderlin M, Haman M, Fletcher PJ (2003). The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism. Psychopharmacology 170, 309-319.
14. Kennett GA, Wood MD, Bright F, Trail B, et al. (1997). SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology 36, 609-620.
15. Michelson D, Adler L, Spencer T, Reimherr FW, et al. (2003). Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biological Psychiatry 53, 112-120.
16. Milstein J, Dalley J, Robbins T (2010). Methylphenidate-induced impulsivity: pharmacological antagonism by beta-adrenoreceptor blockade. Journal of Psychopharmacology 24, 309-321.
17. Mørk A, Witten LM, Arnt J (2009). Effect of sertindole on extracellular dopamine, acetylcholine, and glutamate in the medial prefrontal cortex of conscious rats : a comparison with risperidone and exploration of mechanisms involved. Psychopharmacology 206, 39-49.
18. National Institutes of Health (2010). Guide for the Care and Use of Laboratory Animals, 8th edn. Washington, DC: The National Academies Press.
19. Navailles S, De Deurwaerdère P, Porras G, Spampinato U (2004). In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum. Neuropsychopharmacology 29, 319-326.
20. Navarra R, Graf R, Huang Y, Logue S, et al. (2008). Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. Progress in Neuropsychopharmacology and Biological Psychiatry 32, 34-41.
21. Passetti F, Dalley JW, Robbins TW (2003). Double dissociation of serotonergic and dopaminergic mechanisms on attentional performance using a rodent five-choice reaction time task. Psychopharmacology 165, 136-145.
22. Paterson NE, Ricciardi J, Wetzler C, Hanania T (2011). Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone. Neuroscience Research 69, 41-50.
23. Pattij T, Schetters D, Janssen MC, Wiskerke J, et al. (2009). Acute effects of morphine on distinct forms of impulsive behavior in rats. Psychopharmacology 205, 489-502.
24. Pattij T, Vanderschuren LJ (2008). The neuropharmacology of impulsive behaviour. Trends in Pharmacological Sciences 29, 192-199.
25. Puumala T, Ruotsalainen S, Jäkälä P, Koivisto E, et al. (1996). Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder. Neurobiology of Learning and Memory 66, 198-211.
26. Quérée P, Peters S, Sharp T (2009). Further pharmacological characterization of 5-HT(2C) receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo. British Journal of Pharmacology 158, 1477-1485.
27. Robinson ES, Eagle DM, Mar AC, Bari A, et al. (2008). Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 33, 1028-1037.
28. Ruotsalainen S, Sirviö J, Jäkälä P, Puumala T, et al. (1997). Differential effects of three 5-HT receptor antagonists on the performance of rats in attentional and working memory tasks. European Neuropsychopharmacology 7, 99-108.
29. Schneider T, Ilott N, Brolese G, Bizarro L, et al. (2011). Prenatal exposure to nicotine impairs performance of the 5-choice serial reaction time task in adult rats. Neuropsychopharmacology 36, 1114-1125.
30. Shiels K, Hawk LW, Reynolds B, Mazzullo RJ, et al. (2009). Effects of methylphenidate on discounting of delayed rewards in attention deficit/hyperactivity disorder. Experimental and Clinical Psychopharmacology 17, 291-301.
31. Simpson D, Plosker GL (2004). Atomoxetine : a review of its use in adults with attention deficit hyperactivity disorder. Drugs 64, 205-222.
32. Swanson CJ, Perry KW, Koch-Krueger S, Katner J, et al. (2006). Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat. Neuropharmacology 50, 755-760.
33. Talpos JC, Wilkinson LS, Robbins TW (2006). A comparison of multiple 5-HT receptors in two tasks measuring impulsivity. Journal of Psychopharmacology 20, 47-58.
34. Uslaner JM, Smith SM, Huszar SL, Pachmerhiwala R, et al. (2009). Combined administration of an mGlu2/3 receptor agonist and a 5-HT 2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants. Psychopharmacology 206, 641-651.
35. van Gaalen MM, Brueggeman RJ, Bronius PF, Schoffelmeer AN, et al. (2006). Behavioral disinhibition requires dopamine receptor activation. Psychopharmacology 187, 73-85.
36. Winstanley CA, Eagle DM, Robbins TW (2006). Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clinical Psychology Review 26, 379-395.
37. Winstanley CA, Theobald DE, Dalley JW, Glennon JC, Robbins TW (2004). 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology 176, 376-385.
38. Wiskerke J, Schetters D, van Es IE, van Mourik Y, et al. (2011). m-Opioid receptors in the nucleus accumbens shell region mediate the effects of amphetamine on inhibitory control but not impulsive choice. Journal for Neuroscience 31, 262-272.
39. Wong DT, Threlkeld PG, Best KL, Bymaster FP (1982). A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain. Journal of Pharmacology and Experimental Therapeutics 222, 61-65.
40. Young JW, Light GA, Marston HM, Sharp R, Geyer MA (2009). The 5-choice continuous performance test : evidence for a translational test of vigilance for mice. Public Library of Science One 4, e4227.